Editorial: Targeting ion channels for drug discovery: emerging challenges for high throughput screening technologies

• Ciria C. Hernandez,
• Luis E. Gimenez,
• Tim Strassmaier,
• Marc Rogers,
• Jean-Marc Taymans

Affiliations

Ciria C. Hernandez

Life Sciences Institute, University of Michigan, Ann Arbor, MI, United States

Luis E. Gimenez

Life Sciences Institute, University of Michigan, Ann Arbor, MI, United States

Tim Strassmaier

Nanion Technologies Inc., Livingston, NJ, United States

Marc Rogers

Albion Drug Discovery Services Ltd., Cambridge, United Kingdom

Jean-Marc Taymans

Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France